Report Overview
-
Request a Free Sample to learn more about this report
The global genetically engineered animal models & services market size was valued at USD 3199.1 million in 2022. As per our research, the market is expected to reach USD 4801.1 million by 2029, exhibiting a CAGR expansion of 7.0% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with the genetically engineered animal models & services market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
Genetically Engineered Animal Models (GEAMs) are animals that have been specifically modified at the genetic level to mimic certain traits, conditions, or diseases found in humans or other organisms. These models are widely used in biomedical research to study the underlying mechanisms of diseases, develop and test potential treatments, and gain a better understanding of genetics and physiology.
The market for Genetically Engineered Animal Models (GEAMs) and related services was a significant and growing segment within the broader life sciences and biomedical research industry. The demand for GEAMs and services is driven by the need for better understanding of diseases, drug development, and personalized medicine, among other applications. The GEAMs market has been experiencing steady growth due to the increasing use of genetically modified animals in preclinical research and drug development.
COVID-19 Impact: Market Faced a Fall in Demand Due to Supply Chain Challenges During the Pandemic
There was no single sector unaffected by COVID-19. Genetically Engineered Animal Models & Services Market was affected as well. Supply chain disruptions and restrictions on the movement of goods may have impacted the availability of laboratory reagents, equipment, and animals required for genetically engineered models. This could have affected both ongoing projects and the initiation of new ones.
Latest Trends
"Advancements in Gene Editing Techniques to Improve the Efficiency in the Market "
The Genetically Engineered Animal Models & Services Market is as dynamic as any market. In the market, there is everyday development in the market to add more benefits to it. Recently, the continued development and refinement of gene editing technologies, particularly CRISPR-Cas9 and related techniques, have revolutionized the GEAMs field. These technologies allow for more precise, efficient, and targeted genetic modifications, reducing the time and resources required to generate genetically engineered animals.
Segmentation
-
Request a Free Sample to learn more about this report
- By Type Analysis
According to type, the market can be segmented into Rats, Mice, and Others.
In terms of services, Rats is the largest segment, as it holds the maximum share of the market.
- By Application Analysis
Based on application, the market can be divided into Academic and Research Institutes & Pharmaceutical and Biotechnology Companies.
Driving Factors
"Biomedical Research and Drug Development has Increased Demand in the Market"
Genetically engineered animal models are crucial for understanding disease mechanisms, testing potential drug candidates, and studying the effects of genetic mutations. They play a pivotal role in advancing biomedical research and accelerating the drug development process. As our understanding of genetics and molecular biology advances, the demand for animal models that accurately replicate specific genetic modifications grows. These models are essential for studying the effects of these modifications on health and disease.
"Technological Expertise Influences the Demand in the Market"
Companies that specialize in providing genetically engineered animal models and services offer technological expertise that may not be readily available to individual researchers or smaller organizations. Outsourcing these services can be more efficient and cost-effective. The development and refinement of gene editing technologies, such as CRISPR-Cas9, have greatly improved the efficiency and precision of creating genetically engineered animal models. This has made it easier to generate models with specific genetic modifications, driving the demand for these services. This contributes to the genetically engineered animal models & services market growth.
Restraining Factors
"Technical Challenges Could Lead to a Declining Trend in the Market "
Despite advancements in gene editing technologies, creating genetically engineered animal models with specific genetic modifications can still be technically challenging. Variability in outcomes and the need for extensive validation can be barriers to adopting these models. As a consequence, there can be a declining trend in the market.
Regional Insights
-
Request a Free Sample to learn more about this report
"North America Region Dominates the Market as it has Advanced Research Infrastructure"
North America has the largest genetically engineered animal models & services market share as it boasts a highly developed research infrastructure, including well-established academic institutions, research centers, and biotechnology companies. This infrastructure facilitates the creation, maintenance, and utilization of genetically engineered animal models. Many of the world's largest and most influential biotechnology and pharmaceutical companies are headquartered in North America. These companies have substantial resources to invest in genetically engineered animal models for drug discovery and development. North America has well-defined regulatory frameworks that govern the use of genetically engineered animals in research. Clear regulations and guidelines provide a conducive environment for researchers and companies to navigate the ethical and regulatory aspects of using these models.
Key Industry Players
"Key Players Focus On Research & Development for Creation of Genetically Engineered Animal Models and Collaborations Opportunities in the Market"
Key players are often involved in their own research and development efforts to innovate and improve their offerings. This might include refining gene editing techniques, enhancing phenotyping capabilities, or developing novel animal models. These companies often engage in collaborations and partnerships with academic institutions, research organizations, and pharmaceutical companies. Collaborative efforts can lead to the development of new animal models and research insights. Leading companies actively monitor industry trends, advances in gene editing technologies, and changes in regulatory landscapes to stay at the forefront of the market and provide state-of-the-art solutions. Key players specialize in generating genetically engineered animal models that are designed to mimic specific diseases, study gene functions, or test potential therapeutic interventions. They use cutting-edge gene editing technologies to create animals with precise genetic modifications.
List of Market Players Profile
- Charles River Laboratories (U.S.)
- Envigo (U.S.)
- Taconic Biosciences (U.S.)
- Jackson Laboratory (U.S.)
- Shanghai SLAC (Asia Pacific)
Report Coverage
The report brings together extensive research on the qualitative and quantitative factors affecting the market. It gives an overall macro and micro view of the online reputation service industry. This research profiles a report with extensive studies on the online reputation management services market that describe the firms affecting the forecasting period. Detailed studies also offer a comprehensive analysis by inspecting factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc.
Furthermore, the post-COVID-19 pandemic’s effect on international market restrictions and a deep understanding of how the industry will recover and strategies are also stated in the report. Finally, the competitive landscape has also been examined in detail to provide clarification of the competitive landscape.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 3199.1 Million in 2023 |
Market Size Value By |
US$ 4801.1 Million by 2029 |
Growth Rate |
CAGR of 7% from 2023 to 2029 |
Forecast Period |
2024-2032 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the global Genetically Engineered Animal Models & Services industry expected to touch by 2029?
The global Genetically Engineered Animal Models & Services industry is expected to touch USD 4801.1 million by 2029.
-
What CAGR is the Genetically Engineered Animal Models & Services industry expected to exhibit during 2022-2029?
The global Genetically Engineered Animal Models & Services industry is expected to exhibit a CAGR of 7.0% over 2022-2029.
-
What are the factors which help in pushing the Genetically Engineered Animal Models & Services market?
Biomedical research and drug development and technological expertise are the driving factors of the Genetically Engineered Animal Models & Services market.
-
Which are the key players or most dominating companies functioning in the Genetically Engineered Animal Models & Services market?
Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Crown Biosciences, Shanghai SLAC, Shangghai Modelorg, GenOway, Syngene International, Psychogenics, Pharmaron, Pharmalegacy, Horizon Discovery Group, and Vitalstar Biotechnology are the top companies operating in the Genetically Engineered Animal Models & Services market.